ATOPALM's Technology for trouble free skin
MLE is original technology from NeoPharm that flawlessley mimics the lamellar structure of the natural skin lipids and provides the ultimate in revitalizing the skin's moisture through the restoration of the protetctive barrier system. Ideal for dry and sensitive skin. The special cross pattern of the MLE shows that it is identical to the lipid lamellar structure of the skin. This provides a new standard for dermatalogical science.
MLE is mild and skin friendly because the structure of plant derived ceramides,fatty acids and cholesterol is identical to that of the lipid lamellar structure of the skin. The restoration of the skins' protective moisture barrier system enables it to successfully lock in moisture and help protect the skin from environmental stresses. It is rich, non-greasy, not sticky and quickly absorbed. It soothes and calms agitated skin and softens and smoothes dry, rough skin.
- Patents: Domestic patent registered (KR 1999-0003541),the U.S. patent technology applied (no. US6221371), and Japanese patent technology applied (no. JP38871828
- Clinical tests completed by Yonsei University Medical School and Chungnam University Medical School
- Published research articles in many renowned journals including the Journal of Investigative Dermatology (JID) and the Korean Journal of Investigative Dermatology
 \
ATOPALM Science - Global Technology Approval
OCT 2003
"Effects and
features of the
MLE formulation"
in the Journal of
Investigative
Dermatology
|
FEB 2003
"Clinical results
of the MLE an
atopy dermatitis"
at the International
Society of
Dermatology in
Russia |
JUL 2002
"Clinical results
of ATOPALM" at
the World Congress
of Dermatology in
France
|
MAY 2002
"Skin barriers
and the lamella
structures" at the
Society for
Investigative
Dermatology
|
JUN 2001
Presented clinical
results at the C
& T Society for
Investigative
Dermatology
|
Patents and Certificates
FEB 2006
"Functions and
efforts of a
moisturizer as
an adjunctive
therapy" in the
Journal of
Skin Barrier
Research
|
APR 2005
ATOPALM
patented in China
|
APR 2005
ATOPALM
patented in Korea
|
OCT 2002
Passed Safety
tests
administered
by RCH, an
FDA accredited
institution
|
APR 2001
ATOPALM
patented in the
United States
|
1999
ATOPALM's
ceramide and MLE
formulation
technology won
the KT (Korean
Excellent
Technology).
|
|
Home
